ANDERSON PHILIP J 4

What Happened Philip J. Anderson, Chief Financial Officer of Catheter Precision, Inc. (VTAK), was granted 40,000 derivative securities on 2026-03-26. The report lists an acquisition price of $0.00, so the immediate reported cash value is $0. This transaction is recorded as an award/grant (derivative), not an open-market purchase or sale, and is typically part of executive compensation rather than a direct market buy or sell.

Key Details

• Transaction date: 2026-03-26; Form 4 filed: 2026-03-30.
• Instrument: 40,000 derivative shares (reported as an award/grant) at $0.00.
• Footnote: Options vest 100% on the 180-day anniversary of the grant date.
• Shares owned after transaction: Not specified in the provided filing details.
• No 10b5-1 plan, tax withholding, cashless exercise, or gift noted in the provided info.
• Filing timing: Form 4 was submitted four days after the transaction date (investors may check the full filing for any timeliness flags).

Context This is a compensation-related grant (derivative award) that vests in six months; it does not represent an immediate purchase or sale of shares. For derivative awards like this, pay attention to the vesting schedule and any later filings (Form 4s) showing exercises, sales, or ownership changes once vesting occurs. Such grants are common for executives and do not by themselves indicate insider sentiment to buy or sell stock.